• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当前的高血压管理:分清虚实

Current hypertension management: separating fact from fiction.

作者信息

Moser M

机构信息

Department of Internal Medicine, Yale University School of Medicine.

出版信息

Cleve Clin J Med. 1993 Jan-Feb;60(1):27-37. doi: 10.3949/ccjm.60.1.27.

DOI:10.3949/ccjm.60.1.27
PMID:8443932
Abstract

In medicine, as in other fields, myths or speculations may be repeated so often and so widely that they are perceived as fact. To some extent, this may have occurred with regard to the treatment of hypertension, especially concerning the use of diuretics and beta blockers and the significance of their metabolic effects. An analysis of the available data indicates that the use of diuretics and, to some extent, beta-adrenergic inhibitors will effectively lower blood pressure and reduce morbidity and mortality. Similar analyses strongly suggest that the metabolic changes induced by these agents may not be of major clinical importance. The widespread dissemination of theories and speculations designed to convince physicians to avoid their use may have been overdone. Scientific facts, not extrapolations of data, should be used to make treatment decisions.

摘要

在医学领域,如同在其他领域一样,一些神话或推测可能会被反复且广泛地传播,以至于被人们当作事实。在某种程度上,高血压治疗方面可能就出现了这种情况,尤其是在利尿剂和β受体阻滞剂的使用以及它们代谢效应的重要性方面。对现有数据的分析表明,使用利尿剂以及在一定程度上使用β肾上腺素能抑制剂能有效降低血压,并减少发病率和死亡率。类似的分析有力地表明,这些药物引起的代谢变化可能不具有重大临床意义。那些旨在说服医生避免使用这些药物的理论和推测的广泛传播可能有些过头了。应该依据科学事实,而非数据推断来做出治疗决策。

相似文献

1
Current hypertension management: separating fact from fiction.当前的高血压管理:分清虚实
Cleve Clin J Med. 1993 Jan-Feb;60(1):27-37. doi: 10.3949/ccjm.60.1.27.
2
The diuretic dilemma and the management of mild hypertension.利尿剂困境与轻度高血压的管理
Drugs. 1986;31 Suppl 4:56-67. doi: 10.2165/00003495-198600314-00007.
3
Why are physicians not prescribing diuretics more frequently in the management of hypertension?为什么医生在高血压管理中不更频繁地开利尿剂呢?
JAMA. 1998 Jun 10;279(22):1813-6. doi: 10.1001/jama.279.22.1813.
4
Diuretics in the management of hypertension.
Med Clin North Am. 1987 Sep;71(5):935-46.
5
Diuretics, hypokalemia, and cardiac arrhythmia: a 20-year controversy.利尿剂、低钾血症与心律失常:一场持续20年的争论。
J Clin Hypertens (Greenwich). 2006 Feb;8(2):86-92. doi: 10.1111/j.1524-6175.2005.04722.x.
6
The diuretic dilemma and the management of mild hypertension.
J Clin Hypertens. 1986 Jun;2(2):195-202.
7
[Antihypertensive therapy and modification of metabolic risk factors (glucose and lipid metabolism)].[抗高血压治疗与代谢危险因素(糖脂代谢)的改善]
Z Kardiol. 1992 Jun;81(6):295-302.
8
Suppositions and speculations--their possible effects on treatment decisions in the management of hypertension.假设与推测——它们对高血压管理中治疗决策的可能影响。
Am Heart J. 1989 Dec;118(6):1362-9. doi: 10.1016/0002-8703(89)90059-8.
9
The role of low-dose diuretics in essential hypertension.小剂量利尿剂在原发性高血压中的作用。
J Cardiovasc Pharmacol. 1993;22 Suppl 6:S1-7.
10
Beta-blockers for hypertension.用于治疗高血压的β受体阻滞剂。
Cochrane Database Syst Rev. 2017 Jan 20;1(1):CD002003. doi: 10.1002/14651858.CD002003.pub5.

引用本文的文献

1
Diuretics in primary hypertension - Reloaded.原发性高血压中的利尿剂——再审视
Indian Heart J. 2016 Sep-Oct;68(5):720-723. doi: 10.1016/j.ihj.2016.08.013. Epub 2016 Sep 10.
2
Historical perspectives on the management of hypertension.高血压管理的历史视角
J Clin Hypertens (Greenwich). 2006 Aug;8(8 Suppl 2):15-20; quiz 39. doi: 10.1111/j.1524-6175.2006.05836.x.
3
Is new-onset diabetes of clinical significance in treated hypertensive patients?--Con.新发糖尿病在接受治疗的高血压患者中具有临床意义吗?——结论
J Clin Hypertens (Greenwich). 2006 Feb;8(2):126-32. doi: 10.1111/j.1524-6175.2005.04594.x.
4
Diuretics should continue to be one of the preferred initial therapies in the management of hypertension: the argument for.利尿剂应继续作为高血压管理中首选的初始治疗方法之一:支持该观点的理由。
J Clin Hypertens (Greenwich). 2005 Feb;7(2):111-6; quiz 121-2. doi: 10.1111/j.1524-6175.2005.03943.x.
5
Results of the ALLHAT trial: is the debate about initial antihypertensive drug therapy over?抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)的结果:关于初始抗高血压药物治疗的争论结束了吗?
J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1):5-8. doi: 10.1111/j.1524-6175.2003.02259.x.
6
Should beta blockers be used in the treatment of hypertension in the elderly?β受体阻滞剂是否应用于老年高血压的治疗?
J Clin Hypertens (Greenwich). 2002 Jul-Aug;4(4):286-94. doi: 10.1111/j.1524-6175.2002.01250.x.
7
Diuretics revisited--again.再谈利尿剂——再次探讨。
J Clin Hypertens (Greenwich). 2001 May-Jun;3(3):136-38. doi: 10.1111/j.1524-6175.2001.00468.x.
8
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study.治疗的高血压患者的糖尿病和血清甘油三酯浓度升高——它们具有预后重要性吗?观察性研究。
BMJ. 1996 Sep 14;313(7058):660-3. doi: 10.1136/bmj.313.7058.660.
9
Implementation of local guidelines for cost-effective management of hypertension. A trial of the firm system.实施高血压经济有效管理的地方指南。一项关于公司系统的试验。
J Gen Intern Med. 1996 Mar;11(3):139-46. doi: 10.1007/BF02600265.
10
Torasemide. An update of its pharmacological properties and therapeutic efficacy.托拉塞米。其药理特性与治疗效果的最新进展。
Drugs. 1995 Jan;49(1):121-42. doi: 10.2165/00003495-199549010-00009.